Monitoring brain function in neurocritical care patients
Multimodal Monitoring Study in Neuro Critical Care
This study looks at how brain function changes in patients with serious brain injuries during their first week in critical care to better understand their condition and improve treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (France, Bron) |
| Trial ID | NCT06900101 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with acute cerebral injuries, such as subarachnoidal hemorrhage and traumatic brain injury, during their first week in neurocritical care. It aims to utilize various monitoring techniques, including intracranial pressure monitoring and electroencephalography, to assess brain oxygen consumption and metabolic disorders. The study will explore the correlation between different cerebral autoregulation indices and identify EEG and cardiorespiratory changes in these patients. By doing so, it seeks to enhance understanding of the pathophysiology following brain injuries.
Who should consider this trial
Good fit: Ideal candidates for this study are patients hospitalized in neurologic critical care who are being monitored with the CNS MOBERG® monitoring system.
Not a fit: Patients who refuse to participate or are under legal protection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management strategies for patients with acute brain injuries, potentially reducing the risk of delayed cerebral injuries.
How similar studies have performed: While some monitoring techniques are well-established, the correlation of various cerebral autoregulation indices and their impact on patient outcomes remains largely within the research domain, indicating a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Patients hospitalized in neurologic critical care in Wertheimer Hospital, Bron * Monitored with the CNS MOBERG® monitoring system Exclusion Criteria: * \- Refusal to participate * Patients under legal protection
Where this trial is running
France, Bron
- Hopital Pierre Wertheimer — France, Bron, France (Recruiting)
Study contacts
- Study coordinator: Dr Baptiste Balança
- Email: baptiste.balanca@chu-lyon.fr
- Phone: 04 72 35 75 76
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.